News Focus
News Focus
Followers 4
Posts 5088
Boards Moderated 1
Alias Born 03/21/2024

Re: XMaster2023 post# 753458

Monday, 03/10/2025 7:12:40 PM

Monday, March 10, 2025 7:12:40 PM

Post# of 822488
As an investor, I care about relentless execution and don’t want to hear excuses and victim mindset. If the management team was serious and earnest, they would have submitted reimbursement evidence in parallel or within a quarter or so after MAA submission. Particularly when MAA took itself took over 3 years to submit from the data lock. The trial got over 4.5 years ago.

A company that was serious would have also submitted to another regulatory agency such as FDA and EU. Again, the trial got over 4.5 years ago, but no guidance on US application. US is 20 X of UK in terms of revenue potential. US represents over 50% of the world’s revenue in oncology therapies.

Why would any investors back such a company when all they do is complain, provide excuses, and dangle carrots.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News